Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

aap Implantate AG Confirms FY 2013 Guidance


Wednesday, 14 Aug 2013 04:06am EDT 

aap Implantate AG announced that it reaffirms its sales growth forecast of approximately 10% to EUR 40 million and its EBITDA growth forecast of 15% to EUR 7.0 million. According to I/B/E/S estimates, analysts on average are expecting the Company to report fiscal year 2013 revenue of EUR 38.79 million and EBITDA of EUR 7.12 million.